<bill session="107" type="h" number="4821" updated="2013-07-14T18:58:33-04:00">
  <state datetime="2002-05-22">REFERRED</state>
  <status>
    <introduced datetime="2002-05-22"/>
  </status>
  <introduced datetime="2002-05-22"/>
  <titles>
    <title as="introduced" type="short">Fair Advertising and Increased Research (FAIR) Act</title>
    <title as="introduced" type="official">To amend the Internal Revenue Code of 1986 to limit the deduction for advertising of FDA approved prescription drugs by the manufacturer of such drugs to the level of such manufacturer's research and development expenditures, and for other purposes.</title>
  </titles>
  <sponsor id="400308"/>
  <cosponsors>
    <cosponsor id="400007" joined="2002-05-22"/>
    <cosponsor id="400026" joined="2002-05-22"/>
    <cosponsor id="400050" joined="2002-05-22"/>
    <cosponsor id="400087" joined="2002-06-25"/>
    <cosponsor id="400093" joined="2002-06-25"/>
    <cosponsor id="400100" joined="2002-06-25"/>
    <cosponsor id="400103" joined="2002-05-22"/>
    <cosponsor id="400146" joined="2002-05-22"/>
    <cosponsor id="400195" joined="2002-07-17"/>
    <cosponsor id="400227" joined="2002-06-25"/>
    <cosponsor id="400230" joined="2002-05-22"/>
    <cosponsor id="400528" joined="2002-06-25"/>
    <cosponsor id="400339" joined="2002-05-22"/>
    <cosponsor id="400357" joined="2002-05-22"/>
    <cosponsor id="400378" joined="2002-09-26"/>
    <cosponsor id="400387" joined="2002-05-22"/>
    <cosponsor id="400390" joined="2002-05-22"/>
    <cosponsor id="400430" joined="2002-05-22"/>
    <cosponsor id="400438" joined="2002-05-22"/>
  </cosponsors>
  <actions>
    <action datetime="2002-05-20">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H2651"/>
    </action>
    <action state="REFERRED" datetime="2002-05-22">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="107" type="s" number="2486"/>
  </relatedbills>
  <subjects>
    <term name="Taxation"/>
    <term name="Advertising"/>
    <term name="Appropriations"/>
    <term name="Business income tax"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Economics and public finance"/>
    <term name="Government operations and politics"/>
    <term name="Government trust funds"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Marketing"/>
    <term name="Medicare"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development"/>
    <term name="Sales promotion"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Tax deductions"/>
  </subjects>
  <amendments/>
  <summary>5/22/2002--Introduced.
Fair Advertising and Increased Research Act - Amends the Internal Revenue Code to prohibit any drug manufacturer from taking a tax deduction for expenditures relating to the advertising, promoting, or marketing of any FDA prescription drug to the extent the aggregate amount of such expenditures exceeds the manufacturer's aggregate research and development expenditures.Directs the Secretary of the Treasury to estimate amount of additional tax revenues raised by enforcement of the Act, to be allocated to the Federal Hospital Insurance Trust Fund.</summary>
</bill>
